- Home
- NVNO vs INO Comparison
NVNO vs INO Comparison
Compare NVNO & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- INO
- Stock Information
- Founded
- NVNO 1987
- INO 1979
- Country
- NVNO United States
- INO United States
- Employees
- NVNO N/A
- INO N/A
- Industry
- NVNO Medical/Dental Instruments
- INO Medical/Dental Instruments
- Sector
- NVNO Health Care
- INO Health Care
- Exchange
- NVNO Nasdaq
- INO Nasdaq
- Market Cap
- NVNO 61.9M
- INO 71.5M
- IPO Year
- NVNO N/A
- INO 1998
- Fundamental
- Price
- NVNO $2.89
- INO $2.02
- Analyst Decision
- NVNO
- INO Buy
- Analyst Count
- NVNO 0
- INO 5
- Target Price
- NVNO N/A
- INO $12.40
- AVG Volume (30 Days)
- NVNO 109.6K
- INO 667.3K
- Earning Date
- NVNO 05-07-2025
- INO 03-18-2025
- Dividend Yield
- NVNO N/A
- INO N/A
- EPS Growth
- NVNO N/A
- INO N/A
- EPS
- NVNO N/A
- INO N/A
- Revenue
- NVNO N/A
- INO $203,413.00
- Revenue This Year
- NVNO N/A
- INO N/A
- Revenue Next Year
- NVNO $409.09
- INO $1,970.14
- P/E Ratio
- NVNO N/A
- INO N/A
- Revenue Growth
- NVNO N/A
- INO N/A
- 52 Week Low
- NVNO $2.45
- INO $1.74
- 52 Week High
- NVNO $6.50
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- NVNO 41.66
- INO 43.11
- Support Level
- NVNO $2.65
- INO $1.88
- Resistance Level
- NVNO $3.36
- INO $2.10
- Average True Range (ATR)
- NVNO 0.32
- INO 0.14
- MACD
- NVNO -0.07
- INO 0.00
- Stochastic Oscillator
- NVNO 24.59
- INO 28.30
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.